Recent data indicates that retatrutide, a innovative medication, could represent a significant improvement in weight reduction . This drug combines the actions of a GLP-1 agonist and a GIP agonist , seemingly offering a more benefit than existing approaches . Patient assessments have revealed positive findings , including substantial reductions in